Sign in
4/A

Changes in Ownership

AYTU BIOPHARMA, INC Filed Acc 0001209191-16-139751

Options or other derivatives

  • Chief Executive Officer bought 250,000 shares

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Disbrow Joshua R. Chief Executive Officer 2016-05-06 Purchase · Warrant to Purchase Common Stock +250,000 250,000 D: show line 1 in the form
Loading xslF345X03/doc4a.xml…